Clinical Trial Update: The Role of Lactobacillus Reuteri in Preventing Necrotizing Enterocolitis (NEC) in Pre-term Infants [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating whether Lactobacillus reuteri can prevent necrotizing enterocolitis in pre-term infants, with sepsis as an additional condit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Necrotizing Enterocolitis
• Sepsis

Drugs mentioned

• Lactobacillus reuteri (Lactobacillus reuteri)

Snippet

Sponsor: Children's Hospital and Institute of Child Health, Multan | Conditions: Necrotizing Enterocolitis, Sepsis | Phase 2 | Status: UNKNOWN